Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Halozyme Therapeutics (HALO) Q3 2026 Earnings
HALO
11
Aug
Confirmed
Q4 2025
Q1 2026
Q2 2026
Next
-0.24
0.57
1.39
2.2
Details
Expected EPS
1.803772
Actual EPS
N/A
Surprise EPS
-1.8
Surprise Percent
+100%
Description
Halozyme Therapeutics (HALO) will report earnings of for Q3 2026 on August 11, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login